Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Clinical trial NCT05992935 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05992935
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2026-09-22
- Enrollment
- 1407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.